Pharmacy Intern Training A is designed to be undertaken by pharmacy interns undertaking supervised professional practice while working towards general registration as a pharmacist in Australia, and is intended to complement the learning which occurs in the workplace. It further develops the personal and professional competencies gained on successful completion of an initial pharmacy degree that form the basis of future practice. This unit uses multiple modes of delivery to explore the range of issues that are relevant to the day­to­day practice of pharmacy. This unit of study will support graduates' development and performance in the following domains: professionalism in practice; communication and collaboration; professional expertise; leadership and management; research, inquiry and education.

Pharmacy Intern Training B is designed to be undertaken by pharmacy interns undertaking supervised professional practice while working towards general registration as a pharmacist in Australia, and is intended to complement the learning which occurs in the workplace. It further develops the personal and professional competencies gained on successful completion of an initial pharmacy degree that form the basis of future practice. This unit uses multiple modes of delivery to explore the range of issues that are relevant to the day­to­day practice of pharmacy. This unit of study will support graduates’ development and performance in the following domains: professionalism in practice, communication and collaboration; professional expertise; leadership and management; research, inquiry and education.

This unit of study aims to develop an in-depth understanding and advanced skills in fulfilling the role of pharmacists in medication management for older people. The course readings cover the following content areas: Epidemiology of common health problems affecting older people; physiological changes associated with ageing and their implications for therapeutic response and medicines management; health promotion and disease prevention (with emphasis on pharmacological interventions designed to reduce mortality and chronic disease); management of common chronic diseases of older people; and medication management in hospitals and the community. Skills development will focus on communication with patients; pharmacist, physician, and allied-health inter-professional communication; preparation of medication reviews; and home/residential aged-care facility visits.

This unit of study is intended to develop a clear understanding of the role of pharmacists in the care of patients with diabetes mellitus and the knowledge and skills needed to provide comprehensive pharmaceutical care to this growing section of the Australian population. More specifically, the unit seeks to provide an in-depth understanding of the physiology and pathophysiology of the regulation of glucose metabolism; aetiology, treatment and monitoring of patients with type 1 and type 2 diabetes. Pharmacological and non-pharmacological management; psychosocial issues in diabetes; management and prevention of co-morbidities and complications and public health approaches to the prevention of diabetes. It aims to develop pharmacists' skills in interpretation of relevant clinical and laboratory tests and patterns of blood glucose; supporting patient self-management through advice on appropriate use of blood glucose meters, insulin pens, self-monitoring of blood glucose (SMBG), medication regimen adherence and review, lifestyle changes, management of hypoglycaemia, and sick days. Appropriate pharmacist/patient and inter-professional communication skills will be fostered.

This unit of study will provide an introduction to the background, regulation and quality of complementary medicine products and practices. In addition, the ethical and legal considerations surrounding the provision of complementary medicine advice and supply of products by health care professionals will be covered. Students will be familiarised with reputable and reliable resources of complementary medicine information. These foundational topics will be followed by a series of system-based lectures discussing the current evidence for the efficacy and safety of common complementary medicines used in the management of cardiovascular, respiratory and gastrointestinal health and disease. A combination of lectures, essential reading, evidence and reflective practice reports and online questionnaires will ensure students have a broad understanding of the topics covered.

This unit provides a detailed overview of the processes involved in the development, production and regulation of complementary medicines and devices (with a focus on herbal and nutritional supplement products). In this unit, students will learn foundation concepts and principles of complementary medicines, the regulatory framework, relevant policies and ethical implications (including evidence claims) governing this industry, good manufacturing practice (GMP) and quality standards, submission of product dossiers requirements as well as internationalisation of complementary medicine products (e. g. regulation in Asia and other key areas for export). Students will gain an understanding of the processes and guidelines involved in registering complementary products with the Therapeutic Goods Administration (TGA) in Australia and will be able to assess the level and quality of evidence to support the manufacturer's claim. This unit is suitable for postgraduate students who are working in or interested in entering the complementary medicine development, manufacturing and regulation sector.

This unit of study will cover the aetiology, pathophysiology, diagnosis, treatment and monitoring of the following common mental health problems: anxiety disorders, depression, schizophrenia, bipolar disorders amongst other conditions. This unit of study will focus particularly on medication management issues in people with these conditions and the pharmacist's role in managing these people. It will also focus on the role of the pharmacist within the broader mental health care system in Australia.

This unit of study aims to develop an in-depth understanding of the physiology and pathophysiology of the cardiovascular and renal systems; aetiology, treatment, management and monitoring of patients with renal (including acute and chronic renal failure) and cardiovascular disease (including hypertension, heart failure, coronary heart disease, lipid disorders); It will also explore the role of the specialist cardiovascular/renal pharmacist in management and education of patients and other health care practitioners; public health approaches to the prevention of cardiovascular and renal disease; management and prevention of co-morbidities. Skills development will focus on application of this knowledge to the medication management of patient with cardiovascular and renal disease including interpretation of relevant clinical and laboratory tests, medication review and formulation of appropriate pharmacological and non-pharmacological care plans for these patients.